Pharmacological treatment of Tourette syndrome

被引:16
作者
Gilbert, Donald L. [1 ]
Jankovic, Joseph [2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
Attention deficit; Hyperactivity; Obsessive-ompulsive; Tics; Tourette; DEEP-BRAIN-STIMULATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; PARENT RATING-SCALE; QUALITY-OF-LIFE; DOUBLE-BLIND; TARDIVE-DYSKINESIA; CLINICAL-TRIAL; TIC SEVERITY; CERVICAL MYELOPATHY;
D O I
10.1016/j.jocrd.2014.04.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Tourette syndrome (TS) is a highly heritable yet heterogeneous childhood onset disorder. The cardinal movement disorder required for diagnosis is tics. As persons with tics or TS often have obsessive/compulsiveness, inattention, hyperactivity, impulsivity, anxiety, and anger outbursts, the presence of tics should prompt clinicians to look for these other conditions. While randomized controlled trials provide valid evidence of efficacy for symptoms in isolation, implications for treatment of complex patients meeting criteria for multiple diagnoses is not always clear. In this review, the authors critically review factors influencing decisions whether and how to treat medically tics as well as OCD and ADHD in the presence of tics. (C) 2014 The Authors. Published by Elsevier Inc.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 124 条
  • [1] Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
    Allen, AJ
    Kurlan, RM
    Gilbert, DL
    Coffey, BJ
    Linder, SL
    Lewis, DW
    Winner, PK
    Dunn, DW
    Dure, LS
    Sallee, FR
    Milton, DR
    Mintz, MI
    Ricardi, RK
    Erenberg, G
    Layton, LL
    Feldman, PD
    Kelsey, DK
    Spencer, TJ
    [J]. NEUROLOGY, 2005, 65 (12) : 1941 - 1949
  • [2] Ropinirole in Gilles de la Tourette syndrome
    Anca, MH
    Giladi, N
    Korczyn, AD
    [J]. NEUROLOGY, 2004, 62 (09) : 1626 - 1627
  • [3] [Anonymous], MOVEMENT DISORDER
  • [4] [Anonymous], INT J NEUROPSYCHOPHA
  • [5] [Anonymous], ATOMOXETINE TREATMEN
  • [6] [Anonymous], MOVEMENT DISORDER
  • [7] [Anonymous], EUROPEAN CHILD AD S1
  • [8] Use of levetiracetarn to treat tics in children and adolescents with Tourette syndrome
    Awaad, Y
    Michon, AM
    Minarik, S
    [J]. MOVEMENT DISORDERS, 2005, 20 (06) : 714 - 718
  • [9] Determinants of Quality of Life in Children with Gilles de la Tourette Syndrome
    Bernard, Bryan A.
    Stebbins, Glenn T.
    Siegel, Sandra
    Schultz, Theresa M.
    Hays, Cynthia
    Morrissey, Mary J.
    Leurgans, Sue
    Goetz, Christopher G.
    [J]. MOVEMENT DISORDERS, 2009, 24 (07) : 1070 - 1073
  • [10] Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63